Mcdonough District Hospital

Az itteni vizsgálatok

Miről szól a helyszín 23 vizsgálata, a regiszteri adatlapjaik szerint.

Betegségek

• Mielóma multiplex5 vizsgálat
• Petefészekrák3 vizsgálat
• Gyermekkori daganatok2 vizsgálat
• Melanóma2 vizsgálat
• Prosztatarák2 vizsgálat
• Tüdőrák2 vizsgálat
• Vastagbélrák2 vizsgálat
• Akut limfoid leukémia (ALL)1 vizsgálat
• Akut mieloid leukémia (AML)1 vizsgálat
• Áttétes emlőrák1 vizsgálat
• Diffúz nagy B-sejtes limfóma (DLBCL)1 vizsgálat
• Fej-nyaki daganatok1 vizsgálat
• és még 6

Fázis

• 3. fázis17 vizsgálat
• 2. fázis5 vizsgálat

Állapot

• Fut, nem toboroz12 vizsgálat
• Lezárult11 vizsgálat

Fő szponzor

• National Cancer Institute (NCI)16 vizsgálat
• SWOG Cancer Research Network3 vizsgálat
• Alliance for Clinical Trials in Oncology2 vizsgálat
• ECOG-ACRIN Cancer Research Group1 vizsgálat
• ETOP IBCSG Partners Foundation1 vizsgálat

Futó vizsgálatok

• Fut, nem toboroz

  Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery

  NCT01274338· 3. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma

  NCT01169337· 3. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

  NCT01134614· 2. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer

  NCT01081262· 3. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

  NCT01142388· 2. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

  NCT00588770· 3. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma

  NCT00644228· 3. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

  NCT00602641· 3. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor

  NCT00569127· 3. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

  NCT00114101· 3. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia

  NCT00070499· 2. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Cytogenetic Studies in Acute Leukemia and Multiple Myeloma

  NCT00048958· Alliance for Clinical Trials in Oncology· Forrás

Lezárt vizsgálatok

• Lezárult

  S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma

  NCT01359592· 2. fázis· SWOG Cancer Research Network· Forrás

• Lezárult

  S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery

  NCT01120249· 3. fázis· SWOG Cancer Research Network· Forrás

• Lezárult

  Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer

  NCT01251861· 2. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

  NCT01167712· 3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer

  NCT00601900· 3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide

  NCT00632853· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás

• Lezárult

  Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery

  NCT00324805· 3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer

  NCT00309985· 3. fázis· ECOG-ACRIN Cancer Research Group· Forrás

• Lezárult

  Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer

  NCT00217737· 3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

  NCT00066690· 3. fázis· ETOP IBCSG Partners Foundation· Forrás

• Lezárult

  S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma

  NCT00006721· 3. fázis· SWOG Cancer Research Network· Forrás